International consensus on antinuclear antibody patterns: definition of the AC-29 pattern associated with antibodies to DNA topoisomerase I

Luis E. C. Andrade, Werner Klotz, Manfred Herold, Karsten Conrad, Johan Ronnelid, Marvin J. Fritzler, Carlos A. von Muhlen, Minoru Satoh, Jan Damoiseaux, Wilson de Melo Cruvinel, Edward K. L. Chan, Executive Comm ICAP

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1783-1788
Number of pages6
JournalClinical Chemistry and Laboratory Medicine
Volume56
Issue number10
DOIs
Publication statusPublished - 1 Oct 2018

Keywords

  • antinuclear antibodies
  • autoantibodies
  • HEp-2 cell
  • indirect immunofluorescence
  • SCLERODERMA PATIENTS
  • CELL-PROLIFERATION
  • NUCLEAR ANTIGEN
  • PROTEIN
  • AUTOANTIBODIES
  • SCL-70
  • RECOMMENDATIONS
  • AUTOIMMUNITY
  • AUTOANTIGEN
  • SERA

Cite this

Andrade, L. E. C., Klotz, W., Herold, M., Conrad, K., Ronnelid, J., Fritzler, M. J., von Muhlen, C. A., Satoh, M., Damoiseaux, J., Cruvinel, W. D. M., Chan, E. K. L., & Executive Comm ICAP (2018). International consensus on antinuclear antibody patterns: definition of the AC-29 pattern associated with antibodies to DNA topoisomerase I. Clinical Chemistry and Laboratory Medicine, 56(10), 1783-1788. https://doi.org/10.1515/cclm-2018-0188